{"product_id":"molinahealthcare-swot-analysis","title":"Molina Healthcare SWOT Analysis","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMake Insightful Decisions Backed by Expert Research\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eMolina Healthcare faces stable Medicaid revenue and strong community-focused care models, but regulatory shifts and margin pressure pose meaningful risks; our full SWOT unpacks competitive dynamics, regulatory scenarios, and operational levers you can act on. Purchase the complete SWOT analysis to get a professionally formatted Word report plus an editable Excel matrix—designed for investors, strategists, and advisors seeking clear, research-backed guidance.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eS\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003etrengths\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Lightning-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDominant Medicaid Market Presence\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eMolina Healthcare held Medicaid contracts in 14 states and served about 4.6 million Medicaid members by Q3 2025, giving it a dominant footprint in government-sponsored care.\u003c\/p\u003e\n\u003cp\u003eThat scale delivers deep institutional knowledge and long-standing ties to state regulators, which helped Molina renew multiple managed care contracts through 2024–2025.\u003c\/p\u003e\n\u003cp\u003eFocus on Medicaid yields steadier revenue: in FY 2024 government-sponsored plans made up roughly 80% of Molina’s $24.3 billion revenue, lowering exposure to commercial market swings.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Lightning-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eProven M\u0026amp;A Integration Capabilities\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eMolina Healthcare has repeatedly identified and bought smaller Medicaid plans, integrating them smoothly to add members and scale services.\u003c\/p\u003e\n\u003cp\u003eBy year-end 2025, inorganic growth lifted membership roughly 22% versus 2022, adding about 1.9 million members while keeping SG\u0026amp;A per member flat near $180.\u003c\/p\u003e\n\u003cp\u003eAcquisitions since 2020 drove accretion to adjusted EPS three straight years, making M\u0026amp;A a clear pillar of shareholder value.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Lightning-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eEfficient Medical Cost Management\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eMolina Healthcare keeps medical loss ratio (MLR) tight via advanced analytics and care-management programs; in 2024 Molina reported a consolidated MLR of ~82% vs industry Medicaid avg ~86%, helping deliver operating margin of 3.8% on revenue of $36.1B (FY2024). Their control of utilization and negotiated provider rates stabilizes margins under fixed government payments, a clear edge in the low-margin managed care sector.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Lightning-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eExpansion into Dual-Eligible Populations\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eMolina has scaled offerings for dual-eligible Medicare-Medicaid members, capturing a high-need, higher-margin cohort; duals represented about 18% of membership and ~27% of premium revenue in 2024.\u003c\/p\u003e\n\u003cp\u003eBy 2025 their specialized care models—integrated behavioral, long-term services, and complex care management—have matured, diversifying revenue and cutting per-member-cost growth by an estimated 6% versus Medicaid-only lines.\u003c\/p\u003e\n\u003cp\u003eThis focus matches US aging trends: CMS projects the 65+ population to reach 57 million by 2025, boosting dual-eligible demand and long-term revenue upside for Molina.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eDuals ≈18% membership, ≈27% premium revenue (2024)\u003c\/li\u003e\n\u003cli\u003ePer-member-cost growth down ~6% in dual programs\u003c\/li\u003e\n\u003cli\u003eUS 65+ population ≈57M by 2025 (CMS)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Lightning-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRobust Capital Position\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eMolina Healthcare held cash and equivalents of $2.1 billion and total liquidity near $3.4 billion as of Q3 2025, giving the company flexibility to absorb regulatory shifts and pursue M\u0026amp;A or IT upgrades.\u003c\/p\u003e\n\u003cp\u003eIts disciplined capital allocation funded $230 million in tech\/infrastructure reinvestment in 2024 while paying $150 million in share repurchases and dividends, supporting investor returns and state-level contract confidence.\u003c\/p\u003e\n\u003cp\u003eHere’s the quick math: liquidity covers ~18 months of operating cash burn; tech spend + buybacks = ~2.8% of 2024 revenue.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eCash \u0026amp; equivalents: $2.1B (Q3 2025)\u003c\/li\u003e\n\u003cli\u003eTotal liquidity: $3.4B\u003c\/li\u003e\n\u003cli\u003e2024 tech reinvestment: $230M\u003c\/li\u003e\n\u003cli\u003e2024 buybacks\/dividends: $150M\u003c\/li\u003e\n\u003cli\u003eLiquidity ≈ 18 months operating coverage\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Lightning-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMolina: Medicaid scale, tight margins, strong duals mix and $3.4B liquidity\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eMolina’s Medicaid scale (4.6M members, 14 states Q3 2025) and M\u0026amp;A-driven growth (+1.9M members since 2022) yield steady government revenue (~80% of $24.3B in FY2024), tight MLR (~82% vs Medicaid avg ~86% 2024), strong duals mix (18% membership, 27% premium revenue 2024), and $3.4B liquidity (Q3 2025) supporting ops and deals.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eMembers\u003c\/td\u003e\n\u003ctd\u003e4.6M (Q3 2025)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eStates\u003c\/td\u003e\n\u003ctd\u003e14\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGovt revenue\u003c\/td\u003e\n\u003ctd\u003e~80% of $24.3B (FY2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMLR\u003c\/td\u003e\n\u003ctd\u003e~82% (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDuals\u003c\/td\u003e\n\u003ctd\u003e18% mem \/ 27% rev (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLiquidity\u003c\/td\u003e\n\u003ctd\u003e$3.4B (Q3 2025)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eProvides a concise SWOT overview of Molina Healthcare, highlighting its operational strengths, financial and regulatory weaknesses, market growth opportunities in Medicaid\/Medicare expansion, and external threats from policy changes and competitive pressures.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eProvides a concise Molina Healthcare SWOT snapshot for rapid strategy alignment and stakeholder briefings, highlighting strengths, regulatory risks, market opportunities, and operational threats.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eW\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eeaknesses\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Cloud-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHigh Concentration in Government Programs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eMolina Healthcare derives about 85% of revenue from Medicaid and Medicare, so policy shifts matter: a 10% cut to Medicaid enrollment or funding could dent revenue by roughly $1.7B (2024 revenue $16.8B), and state-level waivers or redeterminations (e.g., 2023–24 Medicaid unwinding) already pressured membership; limited commercial business reduces Molina’s ability to offset political and legislative cycles, raising earnings volatility.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Cloud-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGeographic Concentration Risk\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eDespite expansion, Molina Healthcare still earns about 55% of 2024 revenue from five states, with California and Florida among the largest contributors; losing a major Medicaid contract in one of these could cut revenues by double-digit percentage points in a single year.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Cloud-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLimited Brand Presence in Commercial Markets\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eMolina Healthcare lacks brand recognition and sales infrastructure in employer-sponsored insurance, limiting its total addressable market; commercial membership was just 4% of 2024 revenue according to Molina’s 2024 10-K. This narrow public‑program focus ties the brand to low‑income populations, raising acquisition costs and reducing price leverage when competing with Anthem, UnitedHealth, or Aetna. If Medicaid\/Medicare reimbursement pressure rises, pivoting will be slow and costly.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Cloud-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDependency on State Contract Renewals\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eThe RFP process for state Medicaid contracts is cyclical and highly competitive, creating periodic all-or-nothing risks for Molina Healthcare; losing a major state contract can wipe out millions in annual revenue and trigger mass membership churn (e.g., 2019 California re-bid saw Medicaid enrollment swings \u0026gt;100k members in some plans).\u003c\/p\u003e\n\u003cp\u003eShepherding renewals demands heavy admin, compliance and lobbying spend—Molina reported selling, general \u0026amp; administrative (SG\u0026amp;A) at $3.2B in 2024—stranded costs if a contract is lost remain material.\u003c\/p\u003e\n\u003cp\u003eThe constant defense against larger rivals concentrates operational risk and can depress margins during re-bid cycles, increasing cash flow volatility and capital strain.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eRFPs are cyclical and winner-take-all\u003c\/li\u003e\n\u003cli\u003eLoss can cause large membership churn and stranded costs\u003c\/li\u003e\n\u003cli\u003eHigh SG\u0026amp;A and lobbying burden; $3.2B SG\u0026amp;A (2024)\u003c\/li\u003e\n\u003cli\u003eRe-bids increase margin and cash-flow volatility\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Cloud-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHistorical Vulnerability to Regulatory Audits\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cpmolina healthcare has faced repeated regulatory audits over billing and encounter-data reporting which can trigger fines payment clawbacks or temporary enrollment freezes in molina disclosed a million reserve related to audit exposures. maintaining state federal compliance requires continuous investment it staff training external increasing g operational complexity.\u003e\n\u003cp class=\"lst_crct\"\u003e\u003c\/p\u003e\u003cli\u003e2024 reserve: $255 million\u003c\/li\u003e\u003cli\u003eRisk: fines, clawbacks, enrollment bans\u003c\/li\u003e\u003cli\u003eOngoing compliance costs: higher G\u0026amp;A\u003c\/li\u003e\n\u003c\/pmolina\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Cloud-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMolina: Heavy Medicaid exposure and state concentration risk could cut revenues sharply\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eMolina’s revenues are heavily Medicaid\/Medicare‑weighted (~85% of $16.8B in 2024), concentrating political risk; a 10% Medicaid cut would trim ~ $1.7B. Five states account for ~55% of 2024 revenue, so losing a major contract can dent revenue by double digits. Commercial sales were just 4% of 2024 revenue, limiting offset capacity, while SG\u0026amp;A was $3.2B and regulatory reserves stood at $255M (2024).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024 value\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eRevenue\u003c\/td\u003e\n\u003ctd\u003e$16.8B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMedicaid\/Medicare mix\u003c\/td\u003e\n\u003ctd\u003e~85%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTop‑5 states share\u003c\/td\u003e\n\u003ctd\u003e~55%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCommercial mix\u003c\/td\u003e\n\u003ctd\u003e4%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSG\u0026amp;A\u003c\/td\u003e\n\u003ctd\u003e$3.2B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRegulatory reserve\u003c\/td\u003e\n\u003ctd\u003e$255M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eSame Document Delivered\u003c\/span\u003e\u003cbr\u003eMolina Healthcare SWOT Analysis\u003c\/h2\u003e\n\u003cp\u003eThis is the actual SWOT analysis document you’ll receive upon purchase—no surprises, just professional quality. The preview below is taken directly from the full report, showing real excerpts and structure. Once purchased, you’ll download the complete, editable Molina Healthcare SWOT with in-depth insights and actionable recommendations. The full file unlocks immediately after payment.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56752274538873,"sku":"molinahealthcare-swot-analysis","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/molinahealthcare-swot-analysis.png?v=1772239034","url":"https:\/\/matrixbcg.com\/products\/molinahealthcare-swot-analysis","provider":"MatrixBCG","version":"1.0","type":"link"}